Literature DB >> 20348875

Heart failure: Continuous-flow LVADs improve clinical outcomes.

Yukihiko Nosé.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20348875     DOI： 10.1038/nrcardio.2010.13

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  7 in total

1.  Development of rotary blood pump technology: past, present, and future.

Authors:  Y Nosé; M Yoshikawa; S Murabayashi; T Takano
Journal:  Artif Organs       Date:  2000-06       Impact factor: 3.094

2.  The Thirteenth Hastings lecture. My life with the National Institutes of Health Artificial Heart Program.

Authors:  Y Nosé
Journal:  Artif Organs       Date:  1990-06       Impact factor: 3.094

3.  LVAD power delivery: a percutaneous approach to avoid infection.

Authors:  R Jarvik; S Westaby; T Katsumata; D Pigott; R D Evans
Journal:  Ann Thorac Surg       Date:  1998-02       Impact factor: 4.330

4.  Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.

Authors:  O H Frazier; E A Rose; M C Oz; W Dembitsky; P McCarthy; B Radovancevic; V L Poirier; K A Dasse
Journal:  J Thorac Cardiovasc Surg       Date:  2001-12       Impact factor: 5.209

5.  A miniature implantable axial flow ventricular assist device.

Authors:  M E DeBakey
Journal:  Ann Thorac Surg       Date:  1999-08       Impact factor: 4.330

6.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

7.  Nonpulsatile mode of blood flow required for cardiopulmonary bypass and total body perfusion.

Authors:  Y Nosé
Journal:  Artif Organs       Date:  1993-02       Impact factor: 3.094
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.